搜尋結果
Illumina reaffirms annual revenue forecast over continued sluggish demand
Reuters· 7 小時前, opens new tab reiterated its 2024 revenue forecast on Thursday, expecting continued weak ...
Amgen 'encouraged' by weight-loss drug interim data, shares jump
Reuters· 7 小時前, opens new tab on Thursday said it was very encouraged after completing an interim analysis of ...
Environmental groups sue FEMA, say disaster funds should favor renewables
Reuters· 8 小時前Environmental groups sued the U.S. Federal Emergency Management Agency on Thursday in an ...
GSK, Boehringer Put Profits Over User Safety, Zantac Jury Told
Bloomberg· 8 小時前... Ingelheim GmbH prioritized profits over consumer safety by hiding the cancer& ... ...
Opinion | Boycotting Israel Is an Attack on Science
The Wall Street Journal· 8 小時前Academic deans showed me critiques of research papers that ignored the scientific merits and ...
Opinion | The FDA Will Test You Now
The Wall Street Journal· 8 小時前The agency makes a power grab to regulate lab tests like medical devices.
Amgen scraps experimental weight loss pill, moves forward with injection
CNBC· 9 小時前The Amgen logo is displayed outside Amgen headquarters in Thousand Oaks, California, on May 17, ...
GSK knew about Zantac cancer risk, attorneys tell jury in first trial
Reuters· 11 小時前U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued ...
Regeneron's blockbuster eye drug posts weaker sales due to inventory impact
Reuters· 11 小時前, opens new tab missed Wall Street estimates for quarterly profit on Thursday, hurt by softer ...
Moderna expects CDC to view its RSV vaccine as equal to rival shots
Reuters· 15 小時前, opens new tab said on Thursday it expects U.S. Center for Disease Control and Prevention ...